Zeposia 0.92 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F94S9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,609
Award facts
- Contract value 100% obligated
- $14,609.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,609.25 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count units) on December 8, 2025, with a completion deadline of December 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide. Zeposia (ozanimod) is an oral immunosuppressant used in the treatment of multiple sclerosis and ulcerative colitis, representing the type of specialty pharmaceutical products AmerisourceBergen supplies through its federal contract portfolio.
Quick answers
Who was awarded contract SPE2DR26F94S9?
SPE2DR26F94S9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F94S9 worth?
The government has obligated $14,609 on SPE2DR26F94S9.
Is contract SPE2DR26F94S9 an order under another contract?
Yes. SPE2DR26F94S9 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F94S9 competed?
The extent of competition for SPE2DR26F94S9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award